Cite
MLA Citation
J. Wollenhaupt et al.. “THU0179 Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-label, Long-term Extension up to 6 Years.” Annals of the rheumatic diseases, vol. 74, n.d., p. 259. http://access.bl.uk/ark:/81055/vdc_100135144147.0x000059